BRCA1/2 - Globe Thesis - Globe Thesis

Keyword [BRCA1/2] Result: 21 - 40 \| Page: 2 of 3
21.	Retrospective Analysis Of Clinical Features Of BRCA Mutations In Patients With Recurrent Serous Ovarian Cancer
22.	The Sensitizing Effect Of Mir-509-3 On PARP Inhibitors In High-grade Serous Ovarian Cancer Based On PDX Models
23.	Biological Function And Clinical Characteristics Of PRC1 In High-grade Serous Ovarian Cancer
24.	Relationship Between BRCA1/2 Mutation And Clinicopathological Features In Triple Negative Breast Cancer
25.	Study On BRCA1/2 Germline Mutation In Chinese Patients With HER-2 Negative Metastatic Breast Cancer
26.	The Clinical Characteristics And Prognosis Of Ovarian Cancer With BRCA Mutation:A Meta-analysis
27.	The Preliminary Research Of Clinical Features Of HBOC And Expression Of BRCA1/2 Protein
28.	The Clinicopathologic Characteristic And BRCA1/2 Mutation In Familial Breast Cancer
29.	Identification Of Recurrent Mutations In BRCA1/2 Across Multiple Cancers In Chinese Population
30.	BRCA1/2 Germline Mutations Risk Prediction Nomogram Modles Establishment And Comparison In Early-onset Breast Cancer In China
31.	Detection Of BRCA1/2 Germline Mutations In Chinese Han Woman With Breast Cancer Based On Next-generation Sequencing
32.	BRCA1/2 Germline Mutations In Ovarian Malignant Tumors In Yunnan Province
33.	Retrospective Analysis Of The Relationship Between BRCA,Rad51 Mutations And Recurrence In Patients With Serous Ovarian Cancer And The Treatment Effect Of PARPi
34.	BRCA1/2 Germline Gene Mutation In 43 Cases Of Breast Cancer
35.	Analysis And Generation Database Of BRCA1/2 Variants From Chinese Population
36.	Study On BRCA1/2 Gene Mutations In Female Breast Cancer Patients In Yuxi Area
37.	Negotiation of health risks and risk management for young adult BRCA1/2-positive women: Implications for partnering and family formation
38.	Receiving news of a family BRCA1/2 mutation: Messages of fear and empowerment
39.	Meanings of menopause: Reflections on risk-reducing bilateral salpingo-oophorectomy among women with a BRCA1 or BRCA2 mutation and intact ovaries
40.	Physical activity as a moderator of distress during BRCA1/2 genetic testing
<<First <Prev Next> Last>> Jump to